InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（2 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
2
T+90 胜率
0%
T+90 平均收益
-34.9%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the full record of transactions filed by Lo Andrew, 董事. Officer active across 3 companies, notably AbCellera Biologics Inc.. Cumulatively, 7 reports have been recorded. Breakdown: 2 buys · 2 sells. Total volume traded: €6.7m. History available since 3 December 2021. The latest transaction was filed on 17 November 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Lo Andrew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
7 条申报中的 7 条
About Lo Andrew
Lo Andrew is Administrateur and serves as a director at BridgeBio Pharma, Inc., Roivant Sciences Ltd. and AbCellera Biologics Inc. The 7 filings recorded cover the most recent filings we hold, from 2021-12-07 to 2026-06-24, with EUR 1,146,461 of buys and EUR 5,518,974 of sells in that sample.
